Related Experiment Video
Updated: May 30, 2026
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Iron chelation therapy and thalassemia - an overview
P Chakrabarty1, S Rudra, M A Hossain
1Mymensingh Medical College, Mymensingh, Bangladesh. drpcbabla@yahoo.com
Mymensingh Medical Journal : MMJ
|August 2, 2011
Summary
Advances in thalassemia treatment, including blood transfusions and iron chelation therapy, have improved patient prognosis. New oral chelators offer alternatives, potentially enhancing quality of life for thalassemia patients.
Area of Science:
- Hematology
- Pharmacology
- Genetics
Background:
- Thalassemia treatment has evolved significantly over 30 years.
- Conventional therapy involves blood transfusions and desferrioxamine (DFO) for iron chelation.
- DFO has improved prognosis but faces availability and efficacy challenges.
Purpose of the Study:
- To review new developments in thalassemia epidemiology, treatment, and prognosis.
- To explore alternative iron chelating agents beyond desferrioxamine.
- To discuss the potential impact of new therapies on patient outcomes.
Main Methods:
- Literature review of recent advancements in thalassemia care.
- Analysis of conventional and novel iron chelation strategies.
- Evaluation of treatment efficacy and patient prognosis.
Main Results:
- Parenteral desferrioxamine (DFO) effectively reduces iron accumulation.
- Unavailability and complications with DFO necessitate alternative chelators.
- Deferiprone (DFP), an oral chelator, is now commercially available.
Conclusions:
- Patients may benefit from a choice of chelators, including oral options.
- Combination therapy and organ-targeted chelation show promise.
- Future strategies aim to improve therapeutic outcomes and quality of life for thalassemia patients.
Related Concept Videos
00:57The Periodic Table and Organismal Elements
OverviewElements are the smallest units of matter that cannot be broken down further by chemical processes. There are 118 known elements, but not all of these are naturally-occurring, and fewer still are essential for life. Living matter is composed primarily of carbon, nitrogen, hydrogen, and oxygen, with smaller amounts of other elements like calcium, phosphorus, potassium, and sulfur. Other elements are also necessary for life but only in trace amounts.The Periodic Table Provides Information...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:19Phase II Reactions: Miscellaneous Conjugation Reactions
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...